Interventional Glaucoma: Building a Long-Term Treatment Roadmap

The emergence of procedural pharmaceuticals enhances the ability to use a proactive, staged approach that can preserve vision while reducing the burden of glaucoma care.

John Berdahl, MD

Cataract and Refractive Surgery Today

Modern Thinking for Modern IOL Technology: Rethinking Full-Range Vision, Patient Selection, and Residual Astigmatism

The trade-offs associated with full-range vision have changed, and our approach to counseling, candidacy, and surgical planning should change with them.

Adam Muzychuk, MD, FRCSC

Cataract and Refractive Surgery Today

Finding the Right Fit in Ophthalmology Residency

Bradford L. Tannen, MD, JD, MBA; Daniel B. Moore, MD; Jackson Laureano, MD; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH

Eyetube

Breaking News From the AAO Annual Meeting in New Orleans (Part 2 of 2)

Eyetube

Decreasing the Medication Burden With iDose TR

John P. Berdahl, MD; Natalia Morales, MD; and Justin Schweitzer, OD, FAAO

Eyetube

Going on Offense With Epioxa

Brandon D. Ayres, MD; Parag A. Majmudar, MD; and Neel S. Vaidya, MD, MPH, MBA

Eyetube

Breaking News From the ESCRS Congress in London (Part 2 of 2)

Eyetube

What’s in the Pipeline for DED + OTC Options

Jackie Garlich, OD, FAAO, and Jessilin Quint, OD, FAAO

Eyetube

Harnessing Ocular Physiology: Fast and Sustained Tear Production With TRYPTYR® (acoltremon ophthalmic solution) 0.003% for Dry Eye Disease

Data from the pivotal COMET clinical trials reveal how the first topical ocular neuromodulator approved for the signs and symptoms of DED, TRYPTYR®, delivers a rapid increase in natural tear production.

John Hovanesian, MD (Moderator)*; Marjan Farid, MD*; Nate Lighthizer, OD*; Selina McGee, OD*

Cataract and Refractive Surgery Today

Interventional Glaucoma: Building a Long-Term Treatment Roadmap

The emergence of procedural pharmaceuticals enhances the ability to use a proactive, staged approach that can preserve vision while reducing the burden of glaucoma care.

John Berdahl, MD

Cataract and Refractive Surgery Today

Unlocking Clinical Trial Enrollment with AI Screening

It’s not a patient population problem. It’s a signal-extraction problem.

Sunil Gupta, MD, and Joshua Koo, MS, BS

Retina Today

Rising Stars: Yuxi Zheng, MD

Yuxi Zheng, MD

Retina Today

Subretinal Air

Eyetube

Combining Advanced Visualization and Instrument Selection for Difficult Epiretinal Membranes

Mitul C. Mehta, MD, MS, and J. Ben Margines, MD

Retina Today

Tackling the Documentation Burden

AI can synthesize outside records, draft visit notes, and translate retina jargon, but the physician remains responsible for every word.

Bradley S. Gundlach, MD; Haley S. Garrison, MD, MS; and Prashant D. Tailor, MD

Retina Today